Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Ligand-driven conformational changes of MurD visualized by paramagnetic NMR.

Saio T, Ogura K, Kumeta H, Kobashigawa Y, Shimizu K, Yokochi M, Kodama K, Yamaguchi H, Tsujishita H, Inagaki F.

Sci Rep. 2015 Nov 19;5:16685. doi: 10.1038/srep16685.

2.

A long-term study of istradefylline safety and efficacy in patients with Parkinson disease.

Kondo T, Mizuno Y; Japanese Istradefylline Study Group.

Clin Neuropharmacol. 2015 Mar-Apr;38(2):41-6. doi: 10.1097/WNF.0000000000000073.

PMID:
25768849
3.

Spontaneous movements in the supine position of preterm infants with intellectual disability.

Kouwaki M, Yokochi M, Kamiya T, Yokochi K.

Brain Dev. 2014 Aug;36(7):572-7. doi: 10.1016/j.braindev.2013.08.003. Epub 2013 Sep 19.

PMID:
24055340
4.

Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.

Ikeda M, Mori E, Kosaka K, Iseki E, Hashimoto M, Matsukawa N, Matsuo K, Nakagawa M; Donepezil-DLB Study Investigators.

Dement Geriatr Cogn Disord. 2013;36(3-4):229-41. doi: 10.1159/000351672. Epub 2013 Aug 15.

5.

Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.

Kato K, Mori H, Kito T, Yokochi M, Ito S, Inoue K, Yonezawa A, Katsura T, Kumagai Y, Yuasa H, Moriyama Y, Inui K, Kusuhara H, Sugiyama Y.

Pharm Res. 2014 Jan;31(1):136-47. doi: 10.1007/s11095-013-1144-y. Epub 2013 Aug 2.

PMID:
23907530
6.

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.

Mizuno Y, Nomoto M, Kondo T, Hasegawa K, Murata M, Takeuchi M, Ikeda J, Tomida T, Hattori N; Rotigotine Trial Group.

Mov Disord. 2013 Sep;28(10):1447-50. doi: 10.1002/mds.25537. Epub 2013 Jun 25.

PMID:
23801585
7.

Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects.

Kusuhara H, Miura M, Yasui-Furukori N, Yoshida K, Akamine Y, Yokochi M, Fukizawa S, Ikejiri K, Kanamitsu K, Uno T, Sugiyama Y.

Drug Metab Dispos. 2013 Jan;41(1):206-13. doi: 10.1124/dmd.112.048330. Epub 2012 Oct 31.

8.

Inverse pattern of photoreceptor abnormalities in retinitis pigmentosa and cone-rod dystrophy.

Yokochi M, Li D, Horiguchi M, Kishi S.

Doc Ophthalmol. 2012 Aug 5. [Epub ahead of print]

9.

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial.

Mori E, Ikeda M, Kosaka K; Donepezil-DLB Study Investigators.

Ann Neurol. 2012 Jul;72(1):41-52. doi: 10.1002/ana.23557.

10.

Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS.

Ogaki K, Li Y, Takanashi M, Ishikawa K, Kobayashi T, Nonaka T, Hasegawa M, Kishi M, Yoshino H, Funayama M, Tsukamoto T, Shioya K, Yokochi M, Imai H, Sasaki R, Kokubo Y, Kuzuhara S, Motoi Y, Tomiyama H, Hattori N.

Parkinsonism Relat Disord. 2013 Jan;19(1):15-20. doi: 10.1016/j.parkreldis.2012.06.019. Epub 2012 Jul 18.

PMID:
22818528
11.

Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.

Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M; J-ROCKET AF study investigators.

Circ J. 2012;76(9):2104-11. Epub 2012 Jun 5.

12.

Spontaneous movements in the supine position of healthy term infants and preterm infants with or without periventricular leukomalacia.

Kouwaki M, Yokochi M, Togawa Y, Kamiya T, Yokochi K.

Brain Dev. 2013 Apr;35(4):340-8. doi: 10.1016/j.braindev.2012.05.005. Epub 2012 May 31.

PMID:
22656321
13.

Convenient method for resolving degeneracies due to symmetry of the magnetic susceptibility tensor and its application to pseudo contact shift-based protein-protein complex structure determination.

Kobashigawa Y, Saio T, Ushio M, Sekiguchi M, Yokochi M, Ogura K, Inagaki F.

J Biomol NMR. 2012 May;53(1):53-63. doi: 10.1007/s10858-012-9623-8. Epub 2012 Apr 10.

14.

Effects of physical exercise prescribed by a medical support team on elderly lower extremity osteoarthritis combined with metabolic syndrome and/or type 2 diabetes.

Yokochi M, Watanabe T, Ida K, Yoshida K, Sato Y.

Geriatr Gerontol Int. 2012 Jul;12(3):446-53. doi: 10.1111/j.1447-0594.2011.00790.x. Epub 2011 Dec 28.

PMID:
22212712
15.
16.

An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe.

Saio T, Ogura K, Shimizu K, Yokochi M, Burke TR Jr, Inagaki F.

J Biomol NMR. 2011 Nov;51(3):395-408. doi: 10.1007/s10858-011-9566-5. Epub 2011 Sep 17.

17.

An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR.

Sekiguchi M, Kobashigawa Y, Kawasaki M, Yokochi M, Kiso T, Suzumura K, Mori K, Teramura T, Inagaki F.

Protein Eng Des Sel. 2011 Nov;24(11):811-7. doi: 10.1093/protein/gzr045. Epub 2011 Sep 6.

18.

[A 84-year-old man with apraxia and parkinsonism on his left side,who became bedridden for 6 years].

Takanashi M, Funabe S, Murayama S, Yokochi M.

Brain Nerve. 2011 Aug;63(8):901-8, 909-11. Japanese. No abstract available.

PMID:
21882493
19.

Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

Hori M, Connolly SJ, Ezekowitz MD, Reilly PA, Yusuf S, Wallentin L; RE-LY Investigators.

Circ J. 2011;75(4):800-5. Epub 2011 Mar 19.

20.

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.

Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C; CSPS 2 group.

Lancet Neurol. 2010 Oct;9(10):959-68. doi: 10.1016/S1474-4422(10)70198-8. Epub 2010 Sep 15. Review.

PMID:
20833591
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk